You are here

Dr Billiet and Prof. Ferrante - New therapies in Crohn's disease (CD)

Dr Leuven

Dr Billiet discusses data from a small study from Prague, which looked at relapse rates in 60 patients in endoscopic remission who stopped anti-TNF treatment. Prof. Ferrante discusses the results of the OPERA trial, which treated Crohn's Disease (CD)  patients with an anti-MAdCAM-1 antibody (PF-00547659).

Share

E-Alert

Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.

IBD 13.03.2015

Visit the journal website!

Search form